Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma

Figure 2

First episode of AKI. -axis: time (weeks); 0 = start of first bortezomib administration; -axis: plasma creatinine (mg/dL). VTD: bortezomib-thalidomide-dexamethasone; arrows: bortezomib administration; : time of renal biopsy.